[Form 4] COLGATE PALMOLIVE CO Insider Trading Activity

Rhea-AI Filing Summary

Malcolm Gregory, Executive Vice President and Controller of Colgate-Palmolive Company (CL), reported equity awards granted on 09/11/2025. He received 1,119 restricted stock units (RSUs) that vest in three equal annual installments beginning one year after grant and 7,743 stock options with an exercise price of $84.06. The options vest in equal annual installments over three years beginning on the first anniversary of the grant and expire on 09/11/2033. Following these transactions, Mr. Gregory directly beneficially owns 12,146 shares and indirectly owns 8,445 shares through the issuer's 401(k) plan trustee.

Positive

• Clear alignment with long-term incentives: RSUs and options vest over three years, promoting retention and performance alignment.
• Complete disclosure: Grant amounts, exercise price ($84.06), vesting schedule, and option expiration (09/11/2033) are explicitly reported.

Negative

• Potential future dilution: Exercise of 7,743 options and vesting of 1,119 RSUs would increase shares outstanding if exercised/issued.

Insights

Financial Analyst

TL;DR: Routine executive compensation awards align long-term incentives with shareholders but create potential future dilution.

The reported grant combines time-based restricted stock units and stock options, a common package to retain senior finance executives and link pay to future share performance. The option strike of $84.06 and a nine-year contractual term to 09/11/2033 are in line with standard incentive design that rewards sustained stock appreciation. The vesting schedules (three equal annual installments) emphasize retention over multiple years. From an investor perspective, these are not unusual for an officer-level executive but will create additional share issuance if options are exercised and RSUs vest.

Corporate Governance Expert

TL;DR: Compensation appears procedurally standard with clear vesting; disclosure is complete for Section 16 reporting.

The Form 4 discloses grant types, quantities, vesting cadence, exercise price, and expiration date, meeting transparency expectations for insider reporting. Time-based vesting over three years supports retention objectives and aligns with typical governance practices. The indirect ownership disclosure (8,445 shares via the 401(k) trustee) clarifies the reporting person’s broader economic exposure. No departures from standard disclosure conventions are evident in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Malcolm Gregory

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and Controller

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2025		A(1)		1,119	A	$0.0000	12,146	D
Common Stock								8,445	I	By Issuer's 401(k) Plan Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$84.06	09/11/2025		A(2)		7,743		(3)	09/11/2033	Common Stock	7,743	$0.0000	7,743	D

Explanation of Responses:

1. Restricted stock unit award granted under the issuer's incentive compensation plan. The restricted stock unit award vests in equal 1/3 installments on each of the first, second and third anniversary of the date of grant.

2. Stock option award granted under the issuer's incentive compensation plan.

3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the September 11, 2025 grant date.

	/s/ Kristine Hutchinson, Attorney-in-Fact	09/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Malcolm Gregory receive from Colgate-Palmolive (CL)?

He received 1,119 restricted stock units and 7,743 stock options (exercise price $84.06).

When do Malcolm Gregory's awards vest and when do options expire?

Both RSUs and options vest in three equal annual installments beginning one year after the 09/11/2025 grant; the options expire on 09/11/2033.

How many Colgate shares does Malcolm Gregory beneficially own after the reported transactions?

He directly beneficially owns 12,146 shares and indirectly owns 8,445 shares via the issuer's 401(k) plan trustee.

What is the exercise price of the granted options?

The stock options have an exercise price of $84.06.

Was this Form 4 filed by one reporting person or multiple?

The form indicates it was filed by one reporting person.